| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |